The Atoh7 remote enhancer provides transcriptional robustness during retinal ganglion cell development

The retinal ganglion cell (RGC) competence factor ATOH7 is dynamically expressed during retinal histogenesis. ATOH7 transcription is controlled by a promoter-adjacent primary enhancer and a remote shadow enhancer (SE). Deletion of the ATOH7 human SE causes nonsyndromic congenital retinal nonattachme...

Full description

Saved in:
Bibliographic Details
Published in:Proceedings of the National Academy of Sciences - PNAS Vol. 117; no. 35; pp. 21690 - 21700
Main Authors: Miesfeld, Joel B., Ghiasvand, Noor M., Marsh-Armstrong, Brennan, Marsh-Armstrong, Nicholas, Miller, Eric B., Zhang, Pengfei, Manna, Suman K., Zawadzki, Robert J., Brown, Nadean L., Glaser, Tom
Format: Journal Article
Language:English
Published: United States National Academy of Sciences 01-09-2020
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The retinal ganglion cell (RGC) competence factor ATOH7 is dynamically expressed during retinal histogenesis. ATOH7 transcription is controlled by a promoter-adjacent primary enhancer and a remote shadow enhancer (SE). Deletion of the ATOH7 human SE causes nonsyndromic congenital retinal nonattachment (NCRNA) disease, characterized by optic nerve aplasia and total blindness. We used genome editing to model NCRNA in mice. Deletion of the murine SE reduces Atoh7 messenger RNA (mRNA) fivefold but does not recapitulate optic nerve loss; however, SEdel/knockout (KO) trans heterozygotes have thin optic nerves. By analyzing Atoh7 mRNA and protein levels, RGC development and survival, and chromatin landscape effects, we show that the SE ensures robust Atoh7 transcriptional output. Combining SE deletion and KO and wild-type alleles in a genotypic series, we determined the amount of Atoh7 needed to produce a normal complement of adult RGCs, and the secondary consequences of graded reductions in Atoh7 dosage. Together, these data reveal the workings of an evolutionary fail-safe, a duplicate enhancer mechanism that is hardwired in the machinery of vertebrate retinal ganglion cell genesis.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Author contributions: J.B.M., N.M.G., N.M.-A., N.L.B., and T.G. designed research; J.B.M., B.M.-A., E.B.M., P.Z., S.K.M., and R.J.Z. performed research; B.M.-A. and E.B.M. contributed new reagents/analytic tools; J.B.M., B.M.-A., E.B.M., P.Z., S.K.M., R.J.Z., and T.G. analyzed data; and J.B.M. and T.G. wrote the paper.
Edited by Joseph C. Corbo, Washington University in St. Louis School of Medicine, St. Louis, MO, and accepted by Editorial Board Member Jeremy Nathans July 16, 2020 (received for review April 14, 2020)
ISSN:0027-8424
1091-6490
DOI:10.1073/pnas.2006888117